TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GEBE Medicinsk och Bioteknisk Konsult AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
29
|
19
|
6 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
166
|
-3
|
-38 |
| EBITDA |
161
|
-1
|
-36 |
| Total assets |
353
|
185
|
230 |
| Current assets |
353
|
44
|
74 |
| Current liabilities |
34
|
3
|
10 |
| Equity capital |
314
|
179
|
216 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
89.0%
|
96.8%
|
93.9% |
| Turnover per employee |
14
|
10
|
3 |
| Profit as a percentage of turnover |
572.4%
|
-15.8%
|
-633.3% |
| Return on assets (ROA) |
47.0%
|
-1.6%
|
-16.5% |
| Current ratio |
1038.2%
|
1466.7%
|
740.0% |
| Return on equity (ROE) |
52.9%
|
-1.7%
|
-17.6% |
| Change turnover |
10
|
14
|
1 |
| Change turnover % |
50%
|
229%
|
29% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.